Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-[(4-Methoxyphenyl)sulfonyl]-D-alanine is a small molecule experimental compound. It is classified as an alanine derivative resulting from the reaction of D-alanine at the amino group with a 4-methoxybenzenesulfonyl moiety. The compound has been identified as an inhibitor of macrophage metalloelastase and is considered for research purposes only; it has not been approved for any clinical use[3][1][9]. There are no known indications or clinical trials reported for this drug[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on n-[(4-methoxyphenyl)sulfonyl]-d-alanine.